These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7838436)

  • 21. [Influence of pregnancy on the development of Hodgkin's disease].
    Jouet JP; Buchet-Bouverne B; Fenaux P; Pollet JP; Simon M; Walter MP; Leroy JL; Puech F; Delecour M; Bauters F
    Presse Med; 1988 Mar; 17(9):423-7. PubMed ID: 2966382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET imaging in pediatric Hodgkin's lymphoma.
    Hudson MM; Krasin MJ; Kaste SC
    Pediatr Radiol; 2004 Mar; 34(3):190-8. PubMed ID: 14745528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hodgkin's disease. An old disease with a new face].
    Giraldo P; Franco E
    Sangre (Barc); 1998 Jun; 43(3):171-3. PubMed ID: 9741220
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of Hodgkin's disease: current strategies of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Rüffer U; Josting A; Diehl V
    Ann Oncol; 1999; 10 Suppl 6():23-9. PubMed ID: 10676550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Malignant lymphoma of the neck, nose and pharyngeal region].
    Cerny T
    Schweiz Rundsch Med Prax; 1993 Dec; 82(50):1447-51. PubMed ID: 8290837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
    Tate DJ; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.
    Donaldson SS; Hudson MM; Lamborn KR; Link MP; Kun L; Billett AL; Marcus KC; Hurwitz CA; Young JA; Tarbell NJ; Weinstein HJ
    J Clin Oncol; 2002 Jul; 20(14):3081-7. PubMed ID: 12118021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the treatment of Hodgkin's disease.
    Santoro A; Valagussa P
    Curr Opin Oncol; 1992 Oct; 4(5):821-8. PubMed ID: 1457496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapies in Hodgkin's lymphoma.
    Bartlett N
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):80, 83. PubMed ID: 16163165
    [No Abstract]   [Full Text] [Related]  

  • 31. Classical Hodgkin's lymphoma presenting with tongue involvement: a case report and review of the literature.
    Treaba DO; Eklund JW; Wayne J; Nelson BP; Winter JN
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):410-3. PubMed ID: 16640820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. German Hodgkin's Lymphoma Study Group trials: lessons from the past and current strategies.
    Draube A; Behringer K; Diehl V
    Clin Lymphoma Myeloma; 2006 May; 6(6):458-68. PubMed ID: 16796776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies in the treatment of Hodgkin's disease.
    Straus DJ
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):26-34. PubMed ID: 3541216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hodgkin's lymphoma in adolescents.
    Foltz LM; Song KW; Connors JM
    J Clin Oncol; 2006 Jun; 24(16):2520-6. PubMed ID: 16735704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difficulty in the staging of Hodgkin's disease due to the coexistence of reactive lymphadenopathy.
    Richards EM; Marcus RE
    Leuk Lymphoma; 1993 Mar; 9(4-5):413-8. PubMed ID: 7688629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of advanced stage Hodgkin's lymphoma.
    Bartlett NL; Smukler AJ
    Cancer Treat Res; 2006; 131():333-52. PubMed ID: 16704175
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
    Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
    J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.